Part 1: An Update on the FDA’s Regulation of Digital Pathology

Part 1: An Update on the FDA’s Regulation of Digital Pathology
FDA representative Tremel Faison made it clear last week, during the Regulatory Panel at the Pathology Visions conference, that digital pathology systems will be classified as a class III medical device, requiring manufacturers seeking...
Read more